182 related articles for article (PubMed ID: 30896781)
1. Characteristics of Keratinocyte Carcinomas and Patients with Keratinocyte Carcinomas Following a Single 2-4 Week Course of Topical 5-fluorouracil on the Face and Ears.
Beatson M; Means AD; Leader NF; Robinson-Bostom L; Weinstock MA
Acta Derm Venereol; 2019 Jun; 99(7):707-708. PubMed ID: 30896781
[No Abstract] [Full Text] [Related]
2. Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.
Weinstock MA; Thwin SS; Siegel JA; Marcolivio K; Means AD; Leader NF; Shaw FM; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin GP; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri JE; Robinson-Bostom L; Ringer RJ; Lew RA; Ferguson R; DiGiovanna JJ; Huang GD;
JAMA Dermatol; 2018 Feb; 154(2):167-174. PubMed ID: 29299592
[TBL] [Abstract][Full Text] [Related]
3. Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial.
Weinstock MA; Lee KC; Chren MM; Marcolivio K;
J Am Acad Dermatol; 2009 Aug; 61(2):207-15. PubMed ID: 19398145
[TBL] [Abstract][Full Text] [Related]
4. Rate and Proportion of Malignant Skin Biopsies for Basal Cell and Squamous Cell Carcinoma on the Face and Ears After a Single Course of Topical 5-Fluorouracil: The Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial.
Means AD; Leader NF; Siegel JA; Arron ST; Walker JL; Pomerantz H; Beatson M; Weinstock MA
Dermatol Surg; 2021 Apr; 47(4):541-543. PubMed ID: 33795573
[No Abstract] [Full Text] [Related]
5. Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis.
Yoon J; Phibbs CS; Chow A; Weinstock MA;
J Am Acad Dermatol; 2018 Sep; 79(3):501-507.e2. PubMed ID: 29505863
[TBL] [Abstract][Full Text] [Related]
6. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
Love WE; Bernhard JD; Bordeaux JS
Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
[TBL] [Abstract][Full Text] [Related]
7. Predictors of actinic keratosis count in patients with multiple keratinocyte carcinomas: A cross-sectional study.
Siegel JA; Luber AJ; Weinstock MA;
J Am Acad Dermatol; 2017 Feb; 76(2):346-349. PubMed ID: 28088997
[No Abstract] [Full Text] [Related]
8. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Cunningham TJ; Tabacchi M; Eliane JP; Tuchayi SM; Manivasagam S; Mirzaalian H; Turkoz A; Kopan R; Schaffer A; Saavedra AP; Wallendorf M; Cornelius LA; Demehri S
J Clin Invest; 2017 Jan; 127(1):106-116. PubMed ID: 27869649
[TBL] [Abstract][Full Text] [Related]
9. [Histological findings during the treatment of skin neoplasias with 5-fluorouracil ointment].
Zala L
Dermatologica; 1972; 145(5):326-33. PubMed ID: 4654411
[No Abstract] [Full Text] [Related]
10. [Topical use of antineoplastic agents in precancerous conditions of the skin].
Gartmann H
Z Hautkr; 1977 Apr; 52(8):463-5. PubMed ID: 868199
[No Abstract] [Full Text] [Related]
11. [Topical therapy of precancerous lesions and skin carcinomas using a 5-fluorouracil ointment].
Uthida-Tanaka AM; Nakamura S; de Britto-Costa R; de Tavares Mello E
Hospital (Rio J); 1969 Dec; 76(6):2207-20. PubMed ID: 5309543
[No Abstract] [Full Text] [Related]
12. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
Criscione VD; Weinstock MA; Naylor MF; Luque C; Eide MJ; Bingham SF;
Cancer; 2009 Jun; 115(11):2523-30. PubMed ID: 19382202
[TBL] [Abstract][Full Text] [Related]
13. Effects of increased actinic keratosis count on skin-related quality of life: results from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial.
Beatson M; Siegel JA; Chren MM; Weinstock MA
Eur J Dermatol; 2019 Oct; 29(5):507-510. PubMed ID: 31647464
[TBL] [Abstract][Full Text] [Related]
14. [5-Fluorouracil in local therapy of precancerous conditions and carcinoma of the skin].
Ott F; Storck H
Schweiz Med Wochenschr; 1971 Aug; 101(34):1243-4. PubMed ID: 5141782
[No Abstract] [Full Text] [Related]
15. Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial.
Weinstock MA; Bingham SF; Digiovanna JJ; Rizzo AE; Marcolivio K; Hall R; Eilers D; Naylor M; Kirsner R; Kalivas J; Cole G; Vertrees JE;
J Invest Dermatol; 2012 Jun; 132(6):1583-90. PubMed ID: 22318383
[TBL] [Abstract][Full Text] [Related]
16. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
[TBL] [Abstract][Full Text] [Related]
17. Imiquimod induces sustained remission of actinic damage: a case report spanning one decade of observation.
Knackstedt TJ; Quitadamo M
Cutis; 2015 Feb; 95(2):E20-3. PubMed ID: 25750973
[TBL] [Abstract][Full Text] [Related]
18. Tumors of the skin. XII. Topical 5-Fluorouracil for epidermal neoplasms.
Klein E; Stoll HL; Milgrom H; Helm F; Walker MJ
J Surg Oncol; 1971; 3(3):331-49. PubMed ID: 5110338
[No Abstract] [Full Text] [Related]
19. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.
Karagece Yalçin U; Seçkın S
Turk Patoloji Derg; 2012; 28(2):119-27. PubMed ID: 22627629
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study.
Neugebauer R; Su KA; Zhu Z; Sokil M; Chren MM; Friedman GD; Asgari MM
J Am Acad Dermatol; 2019 Apr; 80(4):998-1005. PubMed ID: 30458208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
